Site Logo

221: CytoDetox – A Breakthrough in Cell Detoxification and Molecular Clinoptilolite

Transcript of Episode 221: CytoDetox – A Breakthrough in Cell Detoxification and Molecular Clinoptilolite

With Dr. Daniel Pompa and Dr. Shayne Morris

Try it for yourself! Purchase CytoDetox® HERE for a limited time, introductory offer!

Dr. Pompa:
On this episode of Cell TV, breakthrough; breaking news in detox. I may have tipped my hand in some of the past shows about the new and improved CytoDetox. In this show, you’re going to hear all about it. This is truly a game changer in detoxification and I believe a game changer in helping the epidemic of conditions that right now people are struggling to fix. This is a show that you’re going to want to watch and share. I am here live on—right here on Systemic Formulas. I am here with the Biochemist himself, Dr. Shayne Morris, who made some new technology possible to fulfill a vision and a dream that I’ve had about detoxification for a long time. He made it happen. Stay tuned for a game-changing Cellular Healing TV. On location today at Systemic Formulas with my favorite—our favorite biochemist, Dr. Shayne Morris. I always say that don’t I?

Dr. Morris:
It’s great.

Dr. Pompa:
He is our favorite because we’ve developed a lot of product together. You’ve developed more product than me, but we’ve developed some specific products together. Okay, today’s topic, this is breaking news. Most people don’t know that we’ve been working on a new CytoDetox for a while.

Dr. Morris:
Yeah, unless they’re coming to your show.

Dr. Pompa:
Yeah, well I had a vision. When we talk about detox—and all of you know this—when I talk about all the pitfalls in detoxification. Cellular detox, if you haven’t seen it, if you’re new to the show, go back, watch. I have a lot of episodes on why real detox has to be at the cell. We have a little cool cell here today. Anyways, why real detox has to be at the cell and the pitfalls of a lot of detox products. I’m big into the science; you’re the scientist. You and I laugh at a lot of these products that people bring to the market. They simply don't work. Some can be dangerous, cause a lot of redistribution. CytoDetox, when it came on the scene, it changed detoxification. It made a lot of things easier, made a lot of things more effective; however, working with hundreds of doctors, I had some visions to take it even to the next level, so we have a new and improved CytoDetox.

This has been in my vision. When I first envisioned this, we got—one of the magic parts about CytoDetox is it has these little particles called clinoptilolite; it’s from a zeolite molecule. We got them in a range that’s able to cross the gut, which was a big issue because zeolite big particles wouldn’t cross the gut, but and also into the membranes, into the cell, and even crossing the blood-brain barrier. The vision was this: I want some particles that are bigger, that have even more binding capacity, and that they don’t cross into the membranes because that would minimize redistribution. Folks, if you can imagine this, we have small particles that have the ability—it doesn’t look that small, but this is a clinoptilolite particle with a binding capacity. It has the ability, the small ones, to cross into the membranes and create detox; however, I wanted some bigger particles that stayed outside the cell. We’ll go halfway with this.

Dr. Morris:
A medium sized.

Dr. Pompa:
Right, a medium sized. I always visualized this as two different products: one that we use to cross into the membranes and one that we use out here to basically clean up if you will, minimize symptoms, better binding capacity, all of that. The problem when I took this to you and others, they said, “Well, the problem is these bigger particles, they don’t even cross the gut.” That’s one of the issues. We were at a standpoint for some years, but the new and improved CytoDetox, we’re going to talk to you about how we broke through some of these challenges. The new and improved CytoDetox has more than just a broader range of size particles. We have small ones, we have medium, and we have even really big ones that probably don’t even leave the gut, but that could be a really good thing. We’ll talk about that. Imagine a new product. Here at the old product, a lot of small particles. Breakthrough in technology: has the ability to cross into the membranes, transform detox. My vision was let’s get some bigger ones that clean up. We could go at a higher dose, minimize symptoms, more effective binder, and even bigger ones yet that don’t leave the gut. We did it in one product. That was a surprise to me. Alright, let’s pull back a little bit. That’s the breaking news, but let’s pull back into this technology. Zeolites, let’s just give some people a little reference about these things and why they’re good for detox.

Dr. Morris:
Yeah, and I like to frame it in what we did for this new product was we put it in three steps or we made it a three-step process. It’s actually very difficult. It took a lot of time and took a lot of energy to intellectually and physically get through each of the three steps. You’ve talked about one of the steps and that is this new distribution of particle sizes. That benefits us in a couple of ways which we’ll get back into.

Dr. Pompa:
Yeah, and let’s not bore people, but lets at least give them the dalton size. The old product, which was extremely effective, and it had from what size to what size?

Dr. Morris:
Two hundred to six hundred.

Dr. Pompa:
Okay, so 200 to 600 size daltons. We’ll call that this size.

Dr. Morris:
Now we’ve gone from 200 up to 2,000 plus.

Dr. Pompa:
We went from here. We have particles this size in about the same number, by the way. Then we have particles up to here.

Dr. Morris:
Much bigger; that’s right.

Dr. Pompa:
In some different ranges; we have some particles this big, with some particles this big. We have arranged from 200 to 2,000 versus 200 to 600.

Dr. Morris:
Right, and we’ll get back to why that’s important in a second. The first step, however, though, you mentioned zeolites. Zeolites tend to be a heavy metal burdened product because you pull it out of the earth. In the earth, that’s what one of their jobs is, they filter. They’re an ion exchange product. They can filter in and trap heavy metals.

Dr. Pompa:
By the way, let me stop you there. We had the Health Ranger, Mike Adams. He was like, “Great, zeolites are great for binding, but they’re dirty products.”

Dr. Morris:
They are.

Dr. Pompa:
He tested the last CytoDetox. He was shocked that hey, this didn’t have all the heavy metals that all these other zeolites on the market have. He was impressed with the cleanliness of the last product; however, when we start making more particles, we could run into more problems with some of that.

Dr. Morris:
Yeah, one of the challenges with zeolites is you’ll notice that most of them on the market, the vast majority that we’ve tested, they have heavy-metal contaminations. What they do is they dilute them to a level that contamination is minimized, but it also minimizes the zeolite product, which minimizes its binding capacity. One of the first steps was to clean the zeolite, cleanness clinoptilolite.

Dr. Pompa:
We needed a new cleaning process, especially because we have more particles and we get bigger particles that potentially have such strong binds. We better clean them even better.

Dr. Morris:
That may have a lot more heavy metals.

Dr. Pompa:
Right, exactly.

Dr. Morris:
To put it in perspective, most of the zeolites we tested, you like to keep things under a half parts per million; that’s .5 ppm or 500 ppb. Again, that’s boring stuff, but when we were bringing in zeolites to do this, they were testing 20, 30, 40 parts per million. That’s extremely high. The only way to either do that is thoroughly clean them, and we had to create new technology to do that, or dilute them. Many companies just dilute them. We opted for the cleaning step.

Dr. Pompa:
You dilute them, you get a cleaner product, but you lose the efficacy.

Dr. Morris:
You do, so we decided that’s not going to work because new and improved means let’s raise the level of clinoptilolite in the formula, but it’s got to be clean. We went through a number of steps. It’s now clean. We’re testing below in some cases 0.2, 0.1. It’s a much cleaner product. That’s the starting point. Once we had that, we knew we could then take it to the next steps, which is step two and three. You mentioned step two, which is changing the size of clinoptilolite.

Dr. Pompa:
Bigger range.

Dr. Morris:
Right, bigger ranges. That really affords us a couple cool things. One, as you mentioned, it can permeate different tissues. It can stay within the GI. From my perspective as a formulator and a scientist, it also does a few things. It becomes more soluble when it’s smaller, which means we can do the step three. It has to be soluble for step three to work, which we’ll get to. Secondly, the binding capacities change dramatically from size. If I only delivered this particle size to the body, I have a very limited binding capacity in the center of this sphere. That’s one of my challenges. If I deliver this product, I can now bind multiple.

Dr. Pompa:
Even more.

Dr. Morris:
If I deliver this product—

Dr. Pompa:
Holy cow.

Dr. Morris:
There’s increasing evidence that this product not only binds multiple heavy metals, but it can also start binding larger molecules. We’re going to do some studies to help prove that. You and I are now looking at larger organic molecules that can fit inside¬—

Dr. Pompa:
Now, look—go ahead.

Dr. Morris:
Mycotoxins is one of them.

Dr. Pompa:
Absolutely, mycotoxins, heavy metals of course.

Dr. Morris:
There are others that I want to look at, but now we’re talking big. There’s a gradient that we can create. We’re now looking at different versions. These are going to be less soluble, so they’re going to stay in the formula and then stay in the GI. These are going to be moderately and then these are going to be highly, so they’re going to be trapped within.

Dr. Pompa:
That’s brilliant. I always say you want some to stay within the GI because that’s where a lot of toxins get dumped. We want these guys to cross the GI but not into the cell. These guys we want to cross and into the cell. That’s the brilliance of the new and improved formula here. Okay, so the problem was when I brought this to scientists and you in the past, then it’s like okay, the problem is that these guys, let’s say these medium guys, we can’t get them across the cell. Of course, we can’t get these guys across—I’m sorry the membrane. We can’t get them across the membrane. I want them in the blood. I don’t necessarily want these in the cell, but I want them in and around the cell to clean up. Why is that important for us? It minimizes redistribution of any metals that get pulled out. When we upregulate cell function, we’re going to start moving metals out that may not get bound into these little guys. Now, we want to clean that up. With these medium guys that don’t go into the membranes, we can clean up. They’re great binders. The problem was you can’t get them across the gut. What did we do to solve the problem?

Dr. Morris:
Yeah, phase three of this entire project was liposomes.

Dr. Pompa:
There you go.

Dr. Morris:
It’s a really old technology; not really, it’s relatively new, but it’s old in the pharmaceutic industry. They have used liposomes to deliver drugs so much more effectively.

Dr. Pompa:
What are they?

Dr. Morris:
What do they look like? That’s a great question. They literally look like a baby cell. They’re a bilayer membrane formed by phosphocholine.

Dr. Pompa:
Okay, here’s that medium size we’re trying to get across.

Dr. Morris:
We’re talking much bigger, so these are going to be big.

Dr. Pompa:
Right, it’s a big, fat molecule if you will that surrounds this guy.

Dr. Morris:
It is.

Dr. Pompa:
Now, why will this not go across the membrane, but this will go across. I’m sorry, I keep saying membrane. The gut barrier.

Dr. Morris:
And membranes. The reason liposomes work is because as I mentioned, they’re a bilayer just like your membranes. This bilayer phosphocholine has an aqueous center which holds all these. Then it has the bilayer membrane that turns it into a sphere almost like a baby cell. When you eat it, you can either leave it in your mouth or as it’s transiting the GI, it fuses with the tissue.

Dr. Pompa:
Got it.

Dr. Morris:
Then it can deliver the contents into—the vast majority of the contents actually get distributed into the lymph tissue.

Dr. Pompa:
The lymph, which goes throughout the body.

Dr. Morris:
Then that course eventually merges with the bloodstream, so we can cross back and forth. We know this technology works because again, the pharma industry has used it over and over again to deliver compounds very effectively. Raises the efficacy of a compound significantly because it essentially bypasses a lot of the GI issues. Now, in our case, that’s not as critical because this is a tough molecule. We still want to get into the bloodstream. Fortunately, with clinoptilolites is they will transit the GI. That’s a point I want to bring up that nobody’s talking about. We talk about these organic binders. I love organic binders, don’t get me wrong, but I love them probably for a different reason than everybody else. Everybody else loves them because they’re considered binders. I love them because I know that the microbiome alters them, metabolizes them, somehow utilizes them in different ways. I’ve seen it over and over again.

Dr. Pompa:
By the way, that’s a problem with Chlorella that is marketed as this amazing metal binder, Cilantro. The microbiome destroys them.

Dr. Morris:
The problem is they contain so many enzymes. To our 23,000 genes, they have 3 million, which means they can produce enzymes that can cut up these organic compounds to use. They want to use them.

Dr. Pompa:
In vitro, they can take Cilantro and go: look, it binds; but there’s no microbiome there.

Dr. Morris:
There’s no microbiome. You’ve got a bunch of enzymes from bacteria, that changes the game. Now, I still think it’s a benefit to my microbiome, but I’m—

Dr. Pompa:
I don’t have a problem with Chlorella, but I have a problem with marketing it as this amazing binder.

Dr. Morris:
As this huge binder and a binder that’s going to make it successfully through the entire GI holding onto something; that I question.

Dr. Pompa:
This particle though—

Dr. Morris:
It’s completely permeable to microbiome because it’s based on a silica type framework. We don’t have the enzymes, neither do microbiome. If we did, you’d see the beaches of the world consumed by organisms. That’s what it’s like. It’s like sand. It’s not going to get consumed, so when it binds up its heavy metals, you’ve got a much greater potential of exiting, having those exit the body through all route of phase three whether it be the urine, skin, and the feces. It’s going to survive.

Dr. Pompa:
Look, okay, let’s just review there’s three things. We zipped right through them already. Number one, why this product is new and improved. Number one?

Dr. Morris:
We had to clean it up.

Dr. Pompa:
Yeah, because we have bigger binders; it binds more. That’s good, but we better have a better way to clean it.

Dr. Morris:
We emptied it out. Before, there was heavy metals in there. By the time we go to size it, this is empty.

Dr. Pompa:
Yeah, ready to bind; right, exactly. Okay, number two, we had a problem obviously with size. Number two?

Dr. Morris:
Number two, size; we broke it into a number of pieces. The small to deliver into tight spaces.

Dr. Pompa:
Tissues; right, exactly, and the cells.

Dr. Morris:
The medium, lymph, blood, so on. Then the large to transit the GI. We made sure using mass spectrometry to maintain those distributions.

Dr. Pompa:
Then because these guys won’t go across the gut readily, then we needed liposomal technology, which is where we are. Okay, there’s one actually thing that we decided. I’m a big fan. You’ve heard me talk about the benefit of multiple types of binders. I believe clinically when you look at cellular detox, we have different binders because different binders bind certain things better than others. Different binders go into different tissues. I’m a big fan of multiple binders. That’s why we use GCEL. That’s why we use Bind in our process. We decided to add yet a different type of binder, which are these: fulvates. This is the fourth thing. Let’s talk about fulvates. Why did we do this?

Dr. Morris:
Fulvates are an amazing binder, too. We were able to get a clean fulvate.

Dr. Pompa:
Big problem.

Dr. Morris:
Again, it’s from nature, clean fulvic acids. We found a nice reliable clean—and it’s soluble. Meaning that it’s going to also be a medium to smaller sized particle. The neat thing about fulvates is one they can bind both metals and some organics. They contribute to the efficacy of the clinoptilolite. We like the combination effect. There’s probably going to be a synergy there between the two.

Dr. Pompa:
Fulvates really go after heavy metals. Talk a little bit about it because people, carbon will bind heavy metals; let’s call them inorganics in this case. It doesn’t do a great job like people think.

Dr. Morris:
It doesn’t do a great job. Remember, metals are highly positively charged. Just straight carbon doesn’t carry out a very significant charge, but fulvates have a lot of oxygens in them. They have some sulfurs and there’s some other things organically speaking, that allow us to form these different interactions. DMSA, that’s a sulfur metal bond.

Dr. Pompa:
Yeah, no, great binder. Yeah, if used correctly.

Dr. Morris:
EDTA, same thing.

Dr. Pompa:
Great binder.

Dr. Morris:
They carry a slightly negative charge which attracts the positive. Fulvates can do that much better than just strict carbon.

Dr. Pompa:
Yeah, the point here is by adding different types of binders with this, now you can see why it is new and improved. These are visions that I have had for a long time. Man, it wouldn’t have happened without you that’s for sure.

Dr. Morris:
No, and the technology gives us some flexibility in the future.

Dr. Pompa:
Yeah, no doubt. Absolutely it gives us flexibility in the future.

Dr. Morris:
Excellent.

Dr. Pompa:
There’s a couple other things that we did better, right?

Dr. Morris:
Yeah.

Dr. Pompa:
Hearing from you, no plastic bottle. This is a glass bottle and we’re not counting drops anymore. We’re actually able to use milliliters; 0.5 to 1-milliliter standard dose on this new product. People are out there with the old one, that’s a really good point: okay, I’m doing 10 drops three times a day or 10 drops two times a day. Starting at 0.5, you’re probably somewhere in the zone up to 1 milliliter. Now, when you pull the dropper out, which is also glass, you can see the 0.5 milliliter all the way to 1 milliliter. I would suggest starting at 0.5 two to three times a day and working up to 1 milliliter two to three times a day.

Dr. Morris:
For those people that read labels, I also want to point out that when I mentioned the dilution effect when you look at a label and you see something that says clinoptilolite MCG. That’s micrograms.

Dr. Pompa:
There’s many products on the market that you and I look at and go, oh my gosh; they’re micrograming this.

Dr. Morris:
Yeah, great idea, but when you look into details, this is just micrograms. We’re delivering milligrams. There’s a thousand-fold difference. This product, it’s at least seven times greater than what we had before. There’s a lot of things we’ve done, things like concentration, bottles, measuring, delivery.

Dr. Pompa:
I’m sitting here talking about it but let me actually just show it to you. Look at this cool box.

Dr. Morris:
That’s new, too.

Dr. Pompa:
That’s new, too. Alright, it comes in the cool box. Then check out the glass bottle.

Dr. Morris:
Isn’t that a cool label?

Dr. Pompa:
Now, if I opened this up, you’d see that even the dropper is glass. That’s a really awesome product here.

Dr. Morris:
There’s a childproof cap. Annoying to some people, but it’s safe that way.

Dr. Pompa:
No, it’s good to do that way. By the way, I have to say the liposome I was super nervous about the taste. We launched this at our seminar and everyone loved it.

Dr. Morris:
It’s a different taste mind you.

Dr. Pompa:
Yeah, well, because first of all, when you use a—you’re making something called Amoxil. That’s the liposome.

Dr. Morris:
Yeah, the liposome, like I say, that double membrane, you have to use different ingredients like ethanol. We used organic ethanol. You have to use sunflower phosphatidylcholine. Then we also use organic glycerin. Those few things together help—with water. Remember, we’re trying to form this little baby cell and all those different ingredients help that form. If you just do water or you just do one of the others, they don’t form.

Dr. Pompa:
A better deliver.

Dr. Morris:
It’s a real science, yeah.

Dr. Pompa:
Yeah, no; totally. This is what pharmaceutical companies do to deliver things. This is amazing. Alright, I know you’re probably saying how do I get it. First of all, if you have a doctor that does cellular detox, go to their office. I’m sure they’re carrying the product. However, I’m going to refer to Matt. You’re going to tell them how to get it because there is even an easier better way. Matt, how can people get the new and improved CytoDetox?

Matt:
Thanks, Dr. Pompa. What we’ve done to make this really easy on everyone watching this right now and to honor the CytoDetox practitioners that are utilizing it in their clinic—and make sure if they have it in their clinic, just go to them and they’ll take care of you. What we’ve done to make it really simple for everyone watching on the show right now is we’ve created this special website: www.buycytonow.com. B-U-Y-C-Y-T-O-N-O-W.com. What we’ve done there is we’ve created a great little video of you, Dr. Pompa, talking more about the cellular technology. We put a special spot in there to continue to honor those practitioners that have clients watching right now. Make sure you put their name in there for the discount. Again, if they’re your clients or followers, Dr. Pompa, they would put your name in there. That just assures that we’re tracking this. That if there’s a practitioner associated with CytoDetox. We just made it really easy that. Go to buycytonow.com. Go there now and that will take care of the rest. There you go, Dr. Pompa. Thank you.

Dr. Pompa:
Thanks, Matt. If I would have done that, I would have screwed it up somehow, so thank you for doing that. Look, I lost my life to this. That’s why this is always an emotional tie when I’m talking about detox. I can’t tell you how many times a week I’m on the phone with somebody and they’re talking about the detox that they did. It either didn’t work and most often, actually makes them worse. You know this. You have to get into the cell for real detox. You’ve got to fix the cell to get well. More specifically, you have to detox the cell. Even more specifically, you have to go at it in the deep tissues in the brain. That’s why this technology, it’s a game changer. I always think to myself: imagine if I would have had this when I was getting my life back. Doing the brain phase, getting ALA, a fat-soluble that goes into the brain. It no doubt helps get the inorganic mercury out of the brain and the deep tissues, but this technology—

Dr. Morris:
Yeah, and I’m with you. We don’t develop these technologies because it’s just exciting. We develop them because we have to stay ahead of this. The challenges are mounting with 80,000 chemicals now that we’re exposed to.

Dr. Pompa:
No, this is a must for people to get their life back. I think the irritating part for me is just the things around detox that are said. I can’t flip on a summit or a podcast and just go railing when I talk about detox, honestly. Oftentimes, I call you or send you an email, “Can you believe that they say this?” Doctors, okay, I give you a pass because you’re not biochemists. For me, the only reason I know some of this stuff is because it’s been my passion. It’s how I got my life back. It’s like as a scientist watching and hearing some of these things that people say about detox or about at least detox products, it must drive you mad.

Dr. Morris:
It drives me insane. I don’t watch a lot of TV, but when I do catch ads on this three-day, one-day.

Dr. Pompa:
Ten-day.

Dr. Morris:
As long as you poop, you’re okay. That is very frustrating.

Dr. Pompa:
Yeah, no, it is.

Dr. Morris:
It’s not addressing anything. It doesn’t make sense.

Dr. Pompa:
When you look at the other zeolite products on the market, when you look at all these detox products on the market, I’m telling you it’s like if you just know some basic science, you’d go, wait a minute. Does that really make sense? Look, we made it easy for you to get. I have to thank you because honestly, this has been a dream and a vision of mine to do this. This is a game changer in the world of detoxification and helping these people get their lives back.

Dr. Morris:
It is; we don’t want to sit still. We want to keep improving.

Dr. Pompa:
Yeah, no doubt. Thanks, man. Love you and appreciate you.

Dr. Morris:
Thank you; love you.

Dr. Pompa:
Yep, I’m sure we’ll have you on another show because just to give you a foreshadow of what’s to come: the microbiome, man. Another one of your specialties.

Dr. Morris:
It’s the next big piece of why I did this.

Dr. Pompa:
Yeah, wait; just wait. Soon there’s a product coming out that you’ve been working on how many years?

Dr. Morris:
Oh man, 2008, ’07, somewhere in there, so 10 years.

Dr. Pompa:
Stay tuned for that show. We’re going to bring it, man. This is a game changer, too. Thanks, guys. We’ll see you on the next one.